What's breaking now, across thousands of outlets.
Factors like inflation, interest rates, A.I. and the war with Iran are far more important, our columnist says.
We haven't written up this one. The New York Times has the full story — the link below goes straight to it.
It’s been a breakout week for Danish biotech Genmab A/S.
German preliminary Q3 Gross Domestic Product (GDP) data arrives at 0.2%, Federal Statistics Office of Germany showed. The growth rate was higher than 0.1% estimates, but slower than 0.3% in the…
Tantalizers Plc nearly doubled its nine-month profit in 2026, as stronger sales, improved gross margins and lower administrative expenses helped
Highlights(1) Delivered strong third-quarter 2026 results, reflecting continued productivity improvements and disciplined execution.
Dis-Chem doubled spending on its X, bigly labs unit as headline earnings per share fell 12.8%.
